Literature DB >> 6384268

Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat.

J A Oliver, R R Sciacca.   

Abstract

Renin is present in vascular smooth muscle cells and has been shown to coexist with angiotensins I (AI) and II (AII) in many cell types. Accordingly, we postulated that the renin-angiotensin system controls vascular tone, not by the action of circulating renal renin but rather, by the local generation of angiotensin by vascular renin. Isolated rat hindquarters were perfused in vitro with Krebs-Henseleit buffer containing 7% albumin, and flow-adjusted to obtain a perfusion pressure of approximately 90 mmHg. Infusion of 4.8 nmol X min-1 for 5 min of AII or AI markedly increased perfusion pressure. An identical dose of the synthetic tetradecaptide of renin substrate (TDCP-RS) increased pressure similarly to AI. The pressure increase evoked by TDCP-RS was markedly decreased by captopril and by two different peptides that inhibit renin. Renin activity in the perfusate, incubated with semipurified rat renin substrate, was 21 +/- 3 pg AI X ml-1 X h-1 (mean +/- SEM) at 15 min of perfusion and 47 +/- 4 pg AI X ml-1 X h-1 at 45 min (n = 9; P less than 0.01). When TDCP-RS was infused at 4.8 nmol X min-1 for 5 min in the presence of captopril, AI in the perfusate increased linearly at a rate of 16.5 pmol X min-1 for 10 min (n = 5). The results indicate that TDCP-RS constricted the vasculature by its conversion to AII and suggest that AII was generated from a two-step hydrolysis of TDCP-RS by renin and converting enzyme. The data thus suggest that the renin-angiotensin system controls vascular tone by the local generation of AII by renin and converting enzyme in the vasculature.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6384268      PMCID: PMC425291          DOI: 10.1172/JCI111534

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Formation of angiotensin II from tetradecapeptide renin substrate by angiotensin-converting enzyme.

Authors:  F E Dorer; J R Kahn; K E Lentz; M Levine; L T Skeggs
Journal:  Biochem Pharmacol       Date:  1975-05-15       Impact factor: 5.858

2.  Renin and angiotensin-like activity in renal lymph.

Authors:  A F LEVER; W S PEART
Journal:  J Physiol       Date:  1962-03       Impact factor: 5.182

3.  Generation of angiotensin II at peripheral vascular level: studies using angiotensin II antisera.

Authors:  J D Swales; H Thurston
Journal:  Clin Sci Mol Med       Date:  1973-11

4.  Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I.

Authors:  J Menard; K J Catt
Journal:  Endocrinology       Date:  1972-02       Impact factor: 4.736

5.  A micromethod for measurement of renin in the plasma and kidney of rats.

Authors:  R Boucher; J Ménard; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1967-09       Impact factor: 2.273

6.  A radioimmunoassay for the direct measurement of renin in mice and its application to submaxillary gland and kidney studies.

Authors:  A M Michelakis; H Yoshida; J Menzie; K Murakami; T Inagami
Journal:  Endocrinology       Date:  1974-04       Impact factor: 4.736

7.  Evidence of renin release or production in splanchnic territory.

Authors:  D Ganten; K Hayduk; H M Brecht; R Boucher; J Genest
Journal:  Nature       Date:  1970-05-09       Impact factor: 49.962

8.  Angiotensin II in arterial and renal venous plasma and renal lymph in the dog.

Authors:  M D Bailie; F C Rector; D W Seldin
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

9.  The preparation, purification, and amino acid sequence of a polypeptide renin substrate.

Authors:  L T SKEGGS; J R KAHN; K LENTZ; N P SHUMWAY
Journal:  J Exp Med       Date:  1957-09-01       Impact factor: 14.307

10.  THE PRESENCE OF RENIN ACTIVITY IN BLOOD VESSEL WALLS.

Authors:  A B GOULD; L T SKEGGS; J R KAHN
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Long-term blood pressure control: is there a set-point in the brain?

Authors:  Yasuhiro Nishida; Megumi Tandai-Hiruma; Takehito Kemuriyama; Kohsuke Hagisawa
Journal:  J Physiol Sci       Date:  2012-05       Impact factor: 2.781

2.  Contribution of the renin-angiotensin system to the intrarenal resistive index in chronic unilateral partial ureteral obstruction in dogs.

Authors:  Hiroshi Yokoyama; Yuji Tsuji
Journal:  J Med Ultrason (2001)       Date:  2005-09       Impact factor: 1.314

3.  Expression of the renin gene in extra-renal tissues of the rat.

Authors:  N J Samani; J D Swales; W J Brammar
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

4.  Local formation of angiotensin II in the rat aorta: effect of endothelium.

Authors:  C Eglème; F Cressier; J M Wood
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

Review 5.  Circulating and tissue angiotensin systems.

Authors:  D J Campbell
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

Review 6.  Biochemistry and pharmacology of the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 7.  Effects of ACE inhibitors on coronary atherosclerosis and restenosis.

Authors:  A D Timmis; B Pitt
Journal:  Br Heart J       Date:  1994-09

Review 8.  Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.

Authors:  Fernando Pedro de Souza-Neto; Melissa Carvalho Santuchi; Mario de Morais E Silva; Maria José Campagnole-Santos; Rafaela Fernandes da Silva
Journal:  Curr Hypertens Rep       Date:  2018-03-14       Impact factor: 5.369

Review 9.  Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.

Authors:  G H Gibbons; V J Dzau
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

10.  Pharmacological evidence for the existence of a local renin-angiotensin system in porcine interlobar renal arteries.

Authors:  E Müller-Schweinitzer; I Olea-Baza
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.